Daxor Corporation Common Stock

Go to Daxor Corporation Common Stock Website

$10.50

0.50 (5.00%)
Live
Previous Close

$10

Day Range

$9.63 - $11.21

Previous Day Range

$9.805 - $10

Market Cap

$49.5 million USD

Day Vol.

1.3 million

Previous Day Vol.

596

Currency

USD

Primary Exchange

Nasdaq

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate,...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Daxor Corporation, a leader in blood volume measurement technology, will showcase its innovative Blood Volume Analysis (BVA) at the MedAxiom Cardiovascular Transforum Spring 2025 conference. WellStar Health System will present findings on how BVA-driven strategies significantly reduced kidney injury following LVAD implantation.

Related tickers: DXR.

Read Full Article

Daxor Corporation, the global leader in blood volume measurement technology, presented new data from Duke University at the American College of Cardiology's annual conference. The research reinforced the value of Daxor's blood volume analysis (BVA) technology in managing heart failure patients, highlighting its superiority over traditional pressure-based assessments.

Related tickers: DXR.

Read Full Article
Trending Tickers

Please sign in to view